Shire finds market hard to please

Pharmaceuticals giant Shire joined the list of big hitters disappointing the market on Thursday with trading updates as the shares turned south on the release of its full year figures.

Pharmaceuticals giant Shire joined the list of big hitters disappointing the market on Thursday with trading updates as the shares turned south on the release of its full year figures.

The group said it has "another strong year" with revenues exceeding $4bn for the first time. Full year product sales were up 26% from a year earlier at $3,950m while total revenues rose 23% to $4,263bn.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
MoneyWeek

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.